Preclinical results presented for CD19-4-1BBL, a CD19-targeting antibody fusion protein April 17, 2018
New phase II trial investigates tislelizumab in relapsed-refractory mature T- and NK-cell lymphomas April 17, 2018
First-in-human study of ATX-GD-59 in patients with Graves' disease meets primary endpoint April 17, 2018
Phase III study in Africa evaluates new combination treatment for visceral leishmaniasis April 17, 2018
RSS